NSC |
Compound |
Enrichment |
Correlation |
NSC 672304 |
Null |
0.0392716453377535 |
0.28173985 |
NSC 676794 |
Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[3-O-(D-.apio.-.beta.-D-ribofuranosy)- 4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-D-xylopy |
0.0392716453377535 |
0.069762878 |
NSC 684409 |
18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone |
0.0392716453377535 |
-0.037337563 |
NSC 693169 |
Null |
0.0392716453377535 |
0.11223694 |
NSC 699934 |
Null |
0.0392716453377535 |
0.32094627 |
NSC 700862 |
4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- |
0.0392716453377535 |
0.18440022 |
NSC 715407 |
Null |
0.0392716453377535 |
0.16020651 |
NSC 718781 |
Erlotinib hydrochloride |
0.0392716453377535 |
-0.25710528 |
NSC 720320 |
1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole |
0.0392716453377535 |
-0.13548075 |
NSC 724783 |
[1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 |
0.0392716453377535 |
0.22407113 |